Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab

Table 1

Clinical and laboratory data before and after tocilizumab injection.

Days	D1	D4	D9	D10	D12	D14	D16
Clinically	Fever	Fever	Fever+	Fever+
WBC; Lymphocytes	12,700; 2.5%	9600; 1.9%	3500; 0.7%		5.2; 1.6%	5.8; 2.1%	10.4; 2.2%
CRP/procal	126/1.3	155/1.54	176/84.2		45/36	7.3/3.9	<2/0.81
Ferritin; D-dimer	1420; 0.7	6910; 2.2	4633; 1.2		3900; 1.0	2105; 0.8	1700; 0.9
eGFR	21	24	24		31	38	36
Rx	Tocilizumab
HR-CT	Done		Done				Done

Severe diarrhea, worsening of cough, tachypnea, and O₂ desaturation. No fever, no diarrhea, and cough less. Asymptomatic.